Genome-wide association analyses of invasive pneumococcal isolates identify a missense bacterial mutation associated with meningitis.
Yuan LiBenjamin J MetcalfSopio ChochuaZhongya LiHollis WalkerTheresa TranPaulina A HawkinsRyan GierkeTamara PilishviliLesley McGeeBernard W BeallPublished in: Nature communications (2019)
Bacterial mutations predisposing pneumococcus to causing meningitis, a more severe form of invasive pneumococcal disease (IPD), are largely unknown. Knowledge of such mutations may improve our understanding of pathogenesis and inform preventive strategies. Here we report a pneumococcal pbp1b gene mutation (pbp1bA641C causing N214T change in PBP1b transglycosylase domain) that is associated with meningitis in an exploratory cohort of IPD patients (n = 2054, p = 6.8 × 10-6), in an independent confirmatory cohort (n = 2518, p = 2.3 × 10-6), and in a combined analysis (n = 4572, p = 3.0 × 10-10). Patients infected by the pbp1b641C genotype pneumococci show 2.8-fold odds (95% CI 1.7 to 4.8) of meningitis compared to those infected by non-pbp1b641C pneumococci, after controlling for pneumococcal serotype, antibiotic resistance, and patient age. The pbp1bA641C change results in longer time needed for bacterial killing by antibiotic treatment and shows evidence of being under positive selection. Thus, a pneumococcal mutation conferring increased antibiotic tolerance is associated with meningitis among IPD patients.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- healthcare
- peritoneal dialysis
- prognostic factors
- cerebrospinal fluid
- autism spectrum disorder
- patient reported outcomes
- intellectual disability
- zika virus
- klebsiella pneumoniae
- patient reported
- aedes aegypti
- combination therapy
- replacement therapy